Germline mutations of FH lead to hereditary leiomyomatosis and renal cell carcinoma (HLRCC), a cancer syndrome characterized by a highly aggressive form of renal cancer. This evidence concerns the gene FH and hereditary leiomyomatosis and renal cell cancer.